fda tirzepatide decision approves new weight-loss drug Zepbound (tirzepatide) Trade association opposes FDA decision

1,2 It is estimated that 20-50% 3 of individuals with diabetes are affected by gastroparesis, while 30% of individuals with gastroparesis have comorbid diabetes 4

If you are in Chandler, AZ, and have been looking for an effective weight loss solution, its time to try GLP-1 medications

Humana and Monogram Health are expanding their in-home kidney care program for Medicare Advantage members into Georgia, now comprising 5 states across the southeast

Because of rising Type 2 diabetes and obesity rates around the globe, semaglutide use is skyrocketing

3 So, what does treatment entail

We found that participants with higher BMI at baseline were more likely to be female, had more volume overload and greater HF symptom severity, and had more severe systemic inflammation at the time of enrollment